摘要 |
The invention relates to quinazoline derivatives of formula (1) wherein m is an integer from 1 to 2; R<SUP>1 </SUP>represents hydrogen, hydroxy, halogeno, nitro, trifluoromethyl, cyano, C<SUB>1-3</SUB>alkyl, C<SUB>1-3</SUB>alkoxy, C<SUB>1-3</SUB>alkylthio, or -NR<SUP>5</SUP>R<SUP>6 </SUP>(wherein R<SUP>5 </SUP>and R<SUP>6</SUP>, which may be the same or different, each represents hydrogen or C<SUB>1-3</SUB>alkyl); R<SUP>2 </SUP>represents hydrogen, hydroxy, halogeno, methoxy, amino or nitro; R<SUP>3 </SUP>represents hydroxy, halogeno, C<SUB>1-3</SUB>alkyl, C<SUB>1-3</SUB>alkoxy, C<SUB>1-3</SUB>alkanoyloxy, trifluoromethyl, cyano, amino or nitro; X<SUP>1 </SUP>represents -O-, -CH<SUB>2</SUB>-, -S-, -SO-, -SO<SUB>2</SUB>-, -NR<SUP>7</SUP>CO-, -CONR<SUP>8</SUP>-, -SO<SUB>2</SUB>NR<SUP>9</SUP>-, -NR<SUB>10</SUB>SO<SUB>2</SUB>- or -NR<SUP>11</SUP>- (wherein R<SUP>7</SUP>, R<SUP>8</SUP>, R<SUP>9</SUP>, R<SUP>10 </SUP>and R<SUP>11 </SUP>each independently represents hydrogen, C<SUB>1-3</SUB>alkyl or C<SUB>1-3</SUB>alkoxyC<SUB>2-3</SUB>alkyl); R<SUP>4 </SUP>represents an optionally substituted 5 or 6 membered saturated carbocyclic or heterocyclic group or a group which is alkenyl, alkynyl or optionally substituted alkyl, which alkyl group may contain a heteroatom linking group, which alkenyl, alkynyl or alkyl group may carry a terminal optionally substituted group selected from alkyl and a 5 or 6 membered saturated carbocyclic or heterocyclic group, and salts thereof; processes for their preparation, pharmaceutical compositions containing a compound of formula (I) or a pharmaceutically acceptable salt thereof as active ingredient. The compounds of formula (I) and pharmaceutically acceptable salts thereof inhibit the effects of VEGF, a property of value in the treatment of a number of disease states including cancer and rheumatoid arthritis.
|